Clinical Trial Update: Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) [Phase 3]

View source ↗

Summary

Phase 3 trial update for metformin/atorvastatin combination therapy in adults with Type 2 diabetes and dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin/atorvastatin combination therapy

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Type II Diabetes, Dyslipidemia | Phase 3 | Status: COMPLETED